Senti Biosciences Holdings, Inc.(SNTI)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Senti Biosciences Holdings, Inc. (SNTI) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SNTI at 14.3/100 on a 32-signal composite quality model, placing it at rank #2,864 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Senti Biosciences Holdings, Inc. reports quarterly revenue of $17.0K, net income of $-12.8M. Top institutional holders of SNTI by reported 13-F value include NEA Management Company, VANGUARD CAPITAL MANAGEMENT, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. SNTI trades on the Nasdaq exchange and files with the SEC under CIK 1854270. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SNTI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Senti Biosciences Holdings, Inc. directly from SEC EDGAR.